AbbVie
Leadership Diversity:
24%
76%
People of Color
White
AbbVie
Leadership Diversity:
38%
62%
Female
Male

AbbVie

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. The company's primary product is Humira (adalimumab) ($14 billion in 2023 revenues, 27 percent of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

Description from Wikipedia

Take Action

Leadership Team